Compare VANI & FCNCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VANI | FCNCP |
|---|---|---|
| Founded | 1998 | N/A |
| Country | United States | United States |
| Employees | N/A | 18141 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.0M | N/A |
| IPO Year | 2014 | 1995 |
| Metric | VANI | FCNCP |
|---|---|---|
| Price | $1.23 | $18.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.83 | N/A |
| AVG Volume (30 Days) | ★ 180.5K | 11.1K |
| Earning Date | 11-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 97.95 |
| Revenue | $4,000,000.00 | ★ $9,541,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.19 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.92 | $18.35 |
| 52 Week High | $1.92 | $22.60 |
| Indicator | VANI | FCNCP |
|---|---|---|
| Relative Strength Index (RSI) | 44.74 | 13.59 |
| Support Level | $1.24 | N/A |
| Resistance Level | $1.25 | $21.39 |
| Average True Range (ATR) | 0.04 | 0.29 |
| MACD | 0.00 | -0.11 |
| Stochastic Oscillator | 53.00 | 1.06 |
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
First Citizens is a US regional bank with total assets of around $237 billion as of June 30, 2026. Headquartered in Raleigh, North Carolina, First Citizens' largest markets are North Carolina, South Carolina, and California. The bank has a track record of acquiring troubled banks from the FDIC, such as Silicon Valley Bridge Bank in 2023, which doubled its asset base. First Citizens offers products and services across retail, commercial, wealth management, and railcar leasing. In 2025, First Citizens derived over 95% of its earnings from banking and less than 5% from railcar leasing.